Member Info for Ipad

Surely we have to wait for the upcoming trial. What if it was incredibly successful ? Would there be a stage 3 trial ?

is he still in ?

What !! First day of the Oval test !!

Well in the short term I would say about £10m. Longer term depends on the news flow.

only £5m..long way to go imho !

worth watching, and it says costs can be 10% of conventional methods. that's a huge increase in profit.

might start saving a few lives !

Great news from Eco. This should move up today.

Why only $20-30 in ground valuation ? With gold at about $1500 an oz I would have thought that would increase the in ground valuation considerably.

oh sorry. I don't read all the messages on here. What do you think then ?

you have to wonder if sp is being kept down until warrants expire, because they don't want to issue new shares at 2p when they know the sp will be much higher when the next news comes out. Oh no, of course they wouldn't do that !

"6-12 months to get approval"...I wonder how many lives that could be ?

3.3 billion shares at £1 each equals £3.3 bn market cap.

10p and I'm out !

Knowlsie. You are always pretty right after the event. Here’s a test for you. What’s your prediction for the SP at the end of the year. You can predict Macp if you prefer.

I’m based in England and the Caribbean.

And including this article from Scancell :-
Cancer vaccine: how far are we from
curing cancer?
An overview of developments in immunotherapy in Moving forward in science communication
treating cancer
with podcasts

Ruhul Choudhury and Lindy Durrant

Don't know what else Tesaro have but the article I read said that Zejula was the main reason for the acquisition

Hi Ray Thanks for the explanation. As you say "Interesting times"

Have just announced promising results from a late stage trial of Zejula, a treatment for ovarian cancer. It cost them $5billion last year.
Makes me wonder what Scancell could be worth if the forthcoming trials produce really good results.